These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 26354213)

  • 1. Efficacy of stem cell in improvement of left ventricular function in acute myocardial infarction--MI3 Trial.
    Nair V; Madan H; Sofat S; Ganguli P; Jacob MJ; Datta R; Bharadwaj P; Sarkar RS; Pandit AJ; Nityanand S; Goel PK; Garg N; Gambhir S; George PV; Chandy S; Mathews V; George OK; Talwar KK; Bahl A; Marwah N; Bhatacharya A; Bhargava B; Airan B; Mohanty S; Patel CD; Sharma A; Bhatnagar S; Mondal A; Jose J; Srivastava A;
    Indian J Med Res; 2015 Aug; 142(2):165-74. PubMed ID: 26354213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial.
    Tendera M; Wojakowski W; Ruzyłło W; Chojnowska L; Kepka C; Tracz W; Musiałek P; Piwowarska W; Nessler J; Buszman P; Grajek S; Breborowicz P; Majka M; Ratajczak MZ;
    Eur Heart J; 2009 Jun; 30(11):1313-21. PubMed ID: 19208649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular systolic and diastolic function improve after acute myocardial infarction treated with acute percutaneous coronary intervention, but are not influenced by intracoronary injection of autologous mononuclear bone marrow cells: a 3 year serial echocardiographic sub-study of the randomized-controlled ASTAMI study.
    Beitnes JO; Gjesdal O; Lunde K; Solheim S; Edvardsen T; Arnesen H; Forfang K; Aakhus S
    Eur J Echocardiogr; 2011 Feb; 12(2):98-106. PubMed ID: 20851818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial.
    Kang HJ; Lee HY; Na SH; Chang SA; Park KW; Kim HK; Kim SY; Chang HJ; Lee W; Kang WJ; Koo BK; Kim YJ; Lee DS; Sohn DW; Han KS; Oh BH; Park YB; Kim HS
    Circulation; 2006 Jul; 114(1 Suppl):I145-51. PubMed ID: 16820564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial.
    Hirsch A; Nijveldt R; van der Vleuten PA; Tijssen JG; van der Giessen WJ; Tio RA; Waltenberger J; ten Berg JM; Doevendans PA; Aengevaeren WR; Zwaginga JJ; Biemond BJ; van Rossum AC; Piek JJ; Zijlstra F;
    Eur Heart J; 2011 Jul; 32(14):1736-47. PubMed ID: 21148540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.
    Meyer GP; Wollert KC; Lotz J; Steffens J; Lippolt P; Fichtner S; Hecker H; Schaefer A; Arseniev L; Hertenstein B; Ganser A; Drexler H
    Circulation; 2006 Mar; 113(10):1287-94. PubMed ID: 16520413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of timing on intracoronary autologous bone marrow-derived cell transplantation in acute myocardial infarction: a meta-analysis of randomized controlled trials.
    Xu JY; Liu D; Zhong Y; Huang RC
    Stem Cell Res Ther; 2017 Oct; 8(1):231. PubMed ID: 29037256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained improvement in left ventricular function after bone marrow derived cell therapy in patients with acute ST elevation myocardial infarction. A 5-year follow-up from the Stem Cell Transplantation in Ischaemic Myocardium Study.
    Moccetti T; Sürder D; Klersy C; Vassalli G; Crljenica C; Rossi MG; Pasotti E; Soldati G
    Swiss Med Wkly; 2012; 142():w13632. PubMed ID: 22833405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in Left Ventricular Function with Intracoronary Mesenchymal Stem Cell Therapy in a Patient with Anterior Wall ST-Segment Elevation Myocardial Infarction.
    Kim SH; Cho JH; Lee YH; Lee JH; Kim SS; Kim MY; Lee MG; Kang WY; Lee KS; Ahn YK; Jeong MH; Kim HS
    Cardiovasc Drugs Ther; 2018 Aug; 32(4):329-338. PubMed ID: 29956042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging.
    Traverse JH; Henry TD; Moye' LA
    Am Heart J; 2011 Oct; 162(4):671-7. PubMed ID: 21982659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combined effect of subcutaneous granulocyte- colony stimulating factor and myocardial contrast echocardiography with intravenous infusion of sulfur hexafluoride on post-infarction left ventricular function, the RIGENERA 2.0 trial: study protocol for a randomized controlled trial.
    Leone AM; D'Amario D; Teofili L; Basile E; Cannata F; Graziani F; Marzilli M; Russo AM; Tarantini G; Ceconi C; Leone G; Trani C; Rebuzzi AG; Crea F
    Trials; 2016 Feb; 17():97. PubMed ID: 26891753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial.
    Roncalli J; Mouquet F; Piot C; Trochu JN; Le Corvoisier P; Neuder Y; Le Tourneau T; Agostini D; Gaxotte V; Sportouch C; Galinier M; Crochet D; Teiger E; Richard MJ; Polge AS; Beregi JP; Manrique A; Carrie D; Susen S; Klein B; Parini A; Lamirault G; Croisille P; Rouard H; Bourin P; Nguyen JM; Delasalle B; Vanzetto G; Van Belle E; Lemarchand P
    Eur Heart J; 2011 Jul; 32(14):1748-57. PubMed ID: 21127322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous intramyocardial delivery of mesenchymal stem cells induces superior improvement in regional left ventricular function compared with bone marrow mononuclear cells in porcine myocardial infarcted heart.
    Tao B; Cui M; Wang C; Ma S; Wu F; Yi F; Qin X; Liu J; Wang H; Wang Z; Ma X; Tian J; Chen Y; Wang J; Cao F
    Theranostics; 2015; 5(2):196-205. PubMed ID: 25553108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized double-blind control study of early intra-coronary autologous bone marrow cell infusion in acute myocardial infarction: the REGENERATE-AMI clinical trial†.
    Choudry F; Hamshere S; Saunders N; Veerapen J; Bavnbek K; Knight C; Pellerin D; Locca D; Westwood M; Rakhit R; Crake T; Kastrup J; Parmar M; Agrawal S; Jones D; Martin J; Mathur A
    Eur Heart J; 2016 Jan; 37(3):256-63. PubMed ID: 26405233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of left ventricular synchronous contraction after acute myocardial infarction by stem cell therapy: new insights into the therapeutic implication of stem cell therapy for acute myocardial infarction.
    Chang SA; Kim HK; Lee HY; Choi SY; Koo BK; Kim YJ; Sohn DW; Oh BH; Park YB; Choi YS; Kang HJ; Kim HS
    Heart; 2008 Aug; 94(8):995-1001. PubMed ID: 17974698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of additional benefit of intracoronary transplantation of autologous peripheral blood stem cell in patients with acute myocardial infarction.
    Choi JH; Choi J; Lee WS; Rhee I; Lee SC; Gwon HC; Lee SH; Choe YH; Kim DW; Suh W; Kim DK; Jeon ES
    Circ J; 2007 Apr; 71(4):486-94. PubMed ID: 17384447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic effects of magnetically labeled mononuclear and mesenchymal stem cells transplantation in a swine myocardial infarction model assessed by magnetic resonance imaging].
    Qi CM; Ma GS; Liu NF; Chen Z; Shen CX; Liu XJ; Hu YP; Su YM; Li X; Zhang XL; Teng GJ; Ju SH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Nov; 36(11):1004-8. PubMed ID: 19102914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prognostic Value of the Left Ventricular Ejection Fraction Is Dependent upon the Severity of Mitral Regurgitation in Patients with Acute Myocardial Infarction.
    Cho JS; Youn HJ; Her SH; Park MW; Kim CJ; Park GM; Jeong MH; Cho JY; Ahn Y; Kim KH; Park JC; Seung KB; Cho MC; Kim CJ; Kim YJ; Han KR; Kim HS;
    J Korean Med Sci; 2015 Jul; 30(7):903-10. PubMed ID: 26130953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial.
    Janssens S; Dubois C; Bogaert J; Theunissen K; Deroose C; Desmet W; Kalantzi M; Herbots L; Sinnaeve P; Dens J; Maertens J; Rademakers F; Dymarkowski S; Gheysens O; Van Cleemput J; Bormans G; Nuyts J; Belmans A; Mortelmans L; Boogaerts M; Van de Werf F
    Lancet; 2006 Jan; 367(9505):113-21. PubMed ID: 16413875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis.
    Delewi R; Hirsch A; Tijssen JG; Schächinger V; Wojakowski W; Roncalli J; Aakhus S; Erbs S; Assmus B; Tendera M; Goekmen Turan R; Corti R; Henry T; Lemarchand P; Lunde K; Cao F; Huikuri HV; Sürder D; Simari RD; Janssens S; Wollert KC; Plewka M; Grajek S; Traverse JH; Zijlstra F; Piek JJ
    Eur Heart J; 2014 Apr; 35(15):989-98. PubMed ID: 24026778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.